Agency: Drug Enforcement Administration
Advanced Search
[FR Doc 05-9836] 76. Robert A. Burkich, M.D.; Revocation of Registration
On August 23, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Robert A. Burkich, M.D. (Dr. Burkich) of Nashville, Tennessee, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration BB4812043,
Published: 2005-05-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9838] 77. Salvatore DeFrank, D.P.M. Revocation of Registration
On October 28, 2004, the Deputy Administrator of the Drug Enforcement Administration (DEA) issued an Order to Show Cause and Immediate Suspension of Registration to Salvatore DeFrank, D.P.M. (Dr. DeFrank) of Dallas, Texas. Dr. DeFrank was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of
Published: 2005-05-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9834] 78. Lance L. Gooberman, M.D.; Denial of Registration
On March 15, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Lance L. Gooberman, M.D. (Dr. Gooberman), notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AG9773703, as a practitioner,
Published: 2005-05-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9837] 79. Katarzyna Rygiel, M.D.; Revocation of Registration
On September 3, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Katarzyna Rygiel, M.D. (Dr. Rygiel) of San Diego, California, notifying her of an opportunity to show cause as to why DEA should not revoke her DEA Certificate of Registration BK4222179,
Published: 2005-05-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9835] 80. Rebecca Sotelo Denial of Registration
On October 6, 2004, the Deputy Assistant Administrator, Office of [[Page 28581]]
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Rebecca Sotelo (Respondent) who was notified of
an opportunity to show cause as to why DEA should not deny her
application for registration as a midlevel practitioner,
Published: 2005-05-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9634] 81. Schedules of Controlled Substances: Placement of Pregabalin into Schedule V
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)3(aminomethyl)5methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from
Published: 2005-05-13 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9538] 82. Preventing the Accumulation of Surplus Controlled Substances at Long Term
DEA is amending its regulations to allow, where State laws permit, for retail pharmacy installation of automated dispensing systems at long term care facilities. Automated dispensing systems would allow dispensing of single dosage units and mitigate the problem of excess stocks and disposal.
Published: 2005-05-13 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9247] 83. Jay D. Angeluzzi, M.D.; Revocation of Registration
On August 23, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Jay D. Angeluzzi, M.D. (Dr. Angeluzzi) who was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration AA2504151, pursuant to 21 U.S.C.
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9251] 84. ELK International, Inc., d.b.a. Tri-City Wholesale; Denial of Application
On April 11, 2003, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to ELK International, Inc., d/b/a TriCity Wholesale (Respondent/Elk) proposing to deny its application for a DEA Certification of Registration as a distributor of list I chemicals. The Order
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9250] 85. James Marvin Goodrich, M.D. Revocation of Registration
On October 24, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to James Marvin Goodrich, M.D. (Dr. Goodrich) of Springfield, Illinois, notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration,
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9252] 86. Jay Enterprises of Spartanburg, Inc.; Denial of Registration
On September 28, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Jay Enterprises of Spartanburg, Inc. (Jay Enterprises/Respondent) proposing to deny its January 15, 2004, application for DEA Certificate of Registration as a distributor of list I
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9246] 87. Stephen K. Jones, M.D.; Denial of Registration
On November 10, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Stephen K. Jones, M.D. (Dr. Jones) who was notified of an opportunity to show cause as to why DEA should not deny his application for DEA Certificate Registration as a practitioner to
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9249] 88. Michael J. Millette, M.D.; Revocation of Registration
On May 17, 2004, the Deputy Administrator of the Drug Enforcement Administration (DEA) issued an Order to Show Cause and Immediate Suspension of Registration to Michael J. Millette, M.D. (Dr. Millette) of Crystal Lake, Illinois and Elizabethtown, Kentucky. Dr. Millette was notified of an opportunity to show cause as to why DEA should not
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9245] 89. Thomas J. Mulhearn, III, M.D.; Revocation of Registration
On August 20, 2004, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Thomas J. Mulhearn, III, M.D. (Dr. Mulhearn) of Monroe,
[[Page 24626]]
Louisiana, notifying him of an opportunity to show cause as to why DEA
should not revoke his DEA Certificate of
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9282] 90. Net Wholesale; Revocation of Registration
On September 16, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Net Wholesale (Net) proposing to revoke its DEA Certificate of Registration 002918NOY as a distributor of List I chemicals pursuant to 21 U.S.C. 824(a)(4), on the ground that Net's
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9248] 91. John S. Poulter, D.D.S; Revocation of Registration
On October 6, 2004, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to John S. Poulter, D.D.S., (Dr. Poulter) notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certification of Registration BP7418177, pursuant to 21 U.S.C.
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9244] 92. Robert A. Smith, M.D.; Revocation of Registration
On September 29, 2004, the Deputy Administrator, Drug Enforcement Administration (DEA), issued an Order to Show Cause/Immediate Suspension of Registration to Robert A. Smith, M.D. (Dr. Smith) who was notified of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration AS2502284 under 21 U.S.C. 824(a)(4)
Published: 2005-05-10 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-9177] 93. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 28, 2004, and published in the Federal Register on July 13, 2004, (69 FR 42068), EliElsohly Laboratories, Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford, Mississippi 38655, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes
Published: 2005-05-09 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8692] 94. Definition and Registration of Reverse Distributors
DEA is finalizing, without change, the interim rule with Request for Comment published in the Federal Register July 11, 2003 at 68 FR 41222. The interim final rule amended Title 21, Code of Federal Regulations, parts 1300, 1301, 1304, 1305 and 1307 to define the term ``reverse distributor'' and establish a new category of registration for persons
Published: 2005-05-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8680] 95. Agency Information Collection Activities: Proposed Collection; Comments
The Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with emergency review procedures of the Paperwork Reduction Act of 1995. OMB approval has been requested by DEA. The proposed information collection is
Published: 2005-05-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8694] 96. Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 18, 2005, Lilly Del Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 00680, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
Published: 2005-05-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8693] 97. Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 5, 2005, Roche Diagnostics Operations Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk
Published: 2005-05-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8140] 98. Manufacturer of Controlled Substances; Notice of Registration
By Notice dated May 18, 2004, and published in the Federal Register on June 3, 2004, (69 FR 3141031411), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
Published: 2005-04-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-8141] 99. Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on February 1, 2005, Penick, Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled
Published: 2005-04-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 05-7820] 100. Importer of Controlled Substances; Notice of Registration; Correction
The notice dated March 29, 2005, and published in the Federal Register on April 6, 2005 (70 FR 17471), contained the following errors: The listing of controlled substances Raw Opium (9600), and Concentrate of Poppy Straw (9670), were inadvertently added for Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee
Published: 2005-04-20 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
Years: 20002001200220032004200520062007200820092010